Key result
Continuing long-term antithrombotic medications, including aspirin and warfarin (if INR ≤ 3.5), prior to dermatological surgery is recommended over discontinuation to avoid thrombosis.
Why the study?
Should antithrombotic medications be continued or stopped prior to dermatological surgery to balance bleeding and thromboembolic risks?
Population
Patients on anticoagulant or antiplatelet medications presenting for a dermatological surgical procedure
Design
Review
Authors
Loading...
Challenges in periprocedural antithrombotic management persist in dermatologic surgery; leaves open need for evidence-based guidelines amid newer agents.
Should antithrombotic medications be continued or stopped prior to dermatological surgery to balance bleeding and thromboembolic risks?
This review recommends that patients on long-term antithrombotic therapy should generally continue their medications prior to dermatological surgery to avoid life-threatening thrombotic events.
Palamaras et al. (2014) conducted a review in Patients on anticoagulant or antiplatelet medications presenting for dermatological surgery. Continuation of antithrombotic medications vs. Discontinuation of antithrombotic medications was evaluated. Continuing long-term antithrombotic medications, including aspirin and warfarin (if INR ≤ 3.5), prior to dermatological surgery is recommended over discontinuation to avoid thrombosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: